DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Dutasteride And Tamsulosin Hydrochloride

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00090103	Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment	Completed	GlaxoSmithKline	Phase 3	2003-11-01	This study will investigate the efficacy and safety of treatment with dutasteride and tamsulosin, administered once daily for 4 years, alone and in combination, on the improvement of symptoms and clinical outcome in men with moderate to severe symptomatic Benign Prostatic Hyperplasia (BPH). Study visits are every 3 months for up to 4 years (18 clinic visits). Transrectal ultrasound (TRUS) is done annually.
NCT00244309	Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer	Completed	GlaxoSmithKline	Phase 3	2005-11-01	The purpose of this study is to determine whether a drug named tamsulosin (Flomax), or another drug named dutasteride (Avodart), or a combination of these two drugs is effective in improving urinary symptoms and decreasing the rate of intermittent self-catheterization after prostate brachytherapy.
NCT00244309	Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer	Completed	Case Comprehensive Cancer Center	Phase 3	2005-11-01	The purpose of this study is to determine whether a drug named tamsulosin (Flomax), or another drug named dutasteride (Avodart), or a combination of these two drugs is effective in improving urinary symptoms and decreasing the rate of intermittent self-catheterization after prostate brachytherapy.

Clinical Trial Conditions for Dutasteride And Tamsulosin Hydrochloride

Condition Name

Condition Name for Dutasteride And Tamsulosin Hydrochloride
Intervention	Trials
Prostatic Hyperplasia	13
Benign Prostatic Hyperplasia	4
Urologic Diseases	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Dutasteride And Tamsulosin Hydrochloride
Intervention	Trials
Prostatic Hyperplasia	17
Hyperplasia	17
Urologic Diseases	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Dutasteride And Tamsulosin Hydrochloride

Trials by Country

Trials by Country for Dutasteride And Tamsulosin Hydrochloride
Location	Trials
United States	41
Germany	31
Italy	20
United Kingdom	12
France	11

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Dutasteride And Tamsulosin Hydrochloride
Location	Trials
Indiana	3
Maryland	3
Texas	2
Ohio	2
New York	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Dutasteride And Tamsulosin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Dutasteride And Tamsulosin Hydrochloride
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	5
Phase 1	11

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Dutasteride And Tamsulosin Hydrochloride
Clinical Trial Phase	Trials
Completed	16
Terminated	2
Active, not recruiting	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Dutasteride And Tamsulosin Hydrochloride

Sponsor Name

Sponsor Name for Dutasteride And Tamsulosin Hydrochloride
Sponsor	Trials
GlaxoSmithKline	18
Siami, Paul F., M.D.	1
Case Comprehensive Cancer Center	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Dutasteride And Tamsulosin Hydrochloride
Sponsor	Trials
Industry	18
Other	7

Export unavailable in trial.
Subscribe for complete access.